EXPONENT INC·4

Jun 29, 6:05 PM ET

Corrigan Catherine 4

4 · EXPONENT INC · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Exponent (EXPO) CEO Catherine Corrigan Exercises Options

What Happened

  • Catherine Corrigan, Chief Executive Officer of Exponent, Inc. (EXPO), exercised a total of 15,744 stock options on 2026-06-25. The filing shows two linked entries of 7,872 option shares each: one resulted in acquisition of 7,872 shares at $25.41 per share for $199,988, and the other shows disposition of 7,872 shares in a derivative transaction (no price listed).
  • This was an options exercise (transaction code M). Exercises are neither direct buys from open market nor sales of existing shares; they convert option rights into company stock.

Key Details

  • Transaction date: 2026-06-25; Form 4 filed: 2026-06-29 (filed within the SEC’s two-business-day window).
  • Prices and values: 7,872 shares acquired at $25.41 each = $199,988; the disposed 7,872 shares are listed as a derivative disposition with no price shown.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: F1 — the option grant becomes exercisable in four equal annual installments; F2 — Not applicable.
  • Filing timeliness: Form filed 6/29 for a 6/25 transaction (timely per Form 4 rules).

Context

  • For option exercises, it’s common for some shares to be surrendered or sold to cover exercise costs or tax withholding; here an equal number of shares were listed as disposed at the time of exercise (the filing does not state the reason). This transaction represents conversion of options into stock rather than an outright market purchase or sale of owned shares.

Insider Transaction Report

Form 4
Period: 2026-06-25
Corrigan Catherine
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-25$25.41/sh+7,872$199,988115,129 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    [F2][F1]
    2026-06-257,8720 total
    Exercise: $25.41Exp: 2026-07-29Common Stock (7,872 underlying)
Footnotes (2)
  • [F1]The stock option becomes exercisable in four equal annual installments.
  • [F2]Not applicable.
Signature
By: Wendy Whitehouse For: Catherine Corrigan|2026-06-29

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT